Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T5QT
|
|||
| Former ID |
DAP000028
|
|||
| Drug Name |
Becaplermin
|
|||
| Synonyms |
Regranex; Regranex (TN); Becaplermin (USAN/INN)
Click to Show/Hide
|
|||
| Indication | Diabetic complication [ICD-11: 5A2Y; ICD-9: 253.5, 588.1] | Approved | [1] | |
| Therapeutic Class |
Antiulcer Agents
|
|||
| Company |
Ortho-McNeil Pharmaceutical
|
|||
| PubChem Substance ID | ||||
| ADReCS Drug ID | BADD_D00216 | |||
| SuperDrug ATC ID |
A01AD08; D03AX06
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Emerging drugs for diabetic foot ulcers. Expert Opin Emerg Drugs. 2006 Nov;11(4):709-24. | |||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.